Skip to content
lifestyle.the-newshub.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
NurExone Biologic Inc
Exo-Top, NurExone’s wholly owned U.S. Subsidiary, Enters Into Binding MOU For Naïve Exosome Distribution in Mexico
June 24, 2026
NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update
June 1, 2026
NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology
May 30, 2026
NurExone Advances to Stage 2 of EU-Backed EIT Health Catapult Programme 2026
May 29, 2026
Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production
May 26, 2026
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
May 25, 2026
NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization
May 24, 2026
NurExone Receives First Place in Healthcare at BOLD Awards VII and Engages Investor Brand Network to Support Awareness Strategy
May 22, 2026
NurExone Announces Corporate Updates
April 29, 2026
NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
February 27, 2026
1
2
Next Page
→